Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-20-001416
Filing Date
2020-02-14
Accepted
2020-02-14 11:00:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 d8476921_13g-a.htm SC 13G/A 116771
  Complete submission text file 0000919574-20-001416.txt   118307
Mailing Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022
Business Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022 (212) 231-4932
ARMISTICE CAPITAL, LLC (Filed by) CIK: 0001601086 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Subject) CIK: 0001634432 (see all company filings)

EIN.: 981130690 | State of Incorp.: L2
Type: SC 13G/A | Act: 34 | File No.: 005-89153 | Film No.: 20615632
SIC: 2834 Pharmaceutical Preparations